Metraipolis › archive › dc_f602a09e39e6

Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential — Europe PMC PMID:42792248

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42792248
DOI
10.3390/antiox15091209
License (as archived)
solo-consultazione
Archived
2026-10-08T02:28:40.171Z
SHA-256 of the archived text
09f21f70e3702d475785214d57dc38dae88f2f5e6134bb8bf7d01a46e60417d3
Stable URL of this page
https://metraipolis.com/documento/dc_f602a09e39e6

How to cite

Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential — Europe PMC PMID:42792248 — Europe PMC (en), https://europepmc.org/article/MED/42792248 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f602a09e39e6 (Metraipolis archive dc_f602a09e39e6, sha256 09f21f70e3702d475785214d57dc38dae88f2f5e6134bb8bf7d01a46e60417d3)
BibTeX
@misc{dcf602a09e39e6,
  title = {Betaine in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanisms of Action and Therapeutic Potential — Europe PMC PMID:42792248},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42792248},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f602a09e39e6; sha256 09f21f70e3702d475785214d57dc38dae88f2f5e6134bb8bf7d01a46e60417d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42792248. Agents can read the archived copy with the MCP tool read_document.